GCM

Glenview Capital Management Portfolio holdings

AUM $5.49B Turnover 46.55%
1-Year Est. Return 46.89%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+46.89%
3 Year Est. Return
+94.27%
5 Year Est. Return
+129.04%
10 Year Est. Return
+529.98%
AUM
$15.3B
AUM Growth
+$1.3B
Cap. Flow
+$1.54B
Cap. Flow %
10.1%
Top 10 Hldgs %
42.05%
Holding
87
New
20
Increased
18
Reduced
21
Closed
19
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.5 years
Top 20 Avg Time Held Equity + Options
0.5 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.5 years

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$383M
2
HRI icon
Herc Holdings
HRI
+$356M
3
EBAY icon
eBay
EBAY
+$298M
4
MON
Monsanto Co
MON
+$266M
5
AET
Aetna Inc
AET
+$251M

Top Sells

Rank Stock Value
1
HMA
HEALTH MGMT ASSOC INC CL-A
HMA
+$495M
2
LIFE icon
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
+$208M
3
PNR icon
Pentair
PNR
+$191M
4
AAP icon
Advance Auto Parts
AAP
+$151M
5
URS
URS CORP
URS
+$114M

Sector Composition

Rank Sector Weight
1 Healthcare 36.39%
2 Consumer Discretionary 11.02%
3 Technology 10.31%
4 Financials 9.85%
5 Communication Services 7.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
TMO icon
1
Thermo Fisher Scientific
TMO
$249B
$1.15B 7.53%
9,560,893
+1,025,800
+12% +$122M
2013 Q2
3 quarters
MON
2
DELISTED
Monsanto Co
MON
$838M 5.49%
7,366,448
+2,392,918
+48% +$266M
2013 Q3
2 quarters
HCA icon
3
HCA Healthcare
HCA
$101B
$674M 4.42%
12,841,713
– –
2013 Q2
3 quarters
CCI icon
4
Crown Castle
CCI
$33.5B
$623M 4.08%
8,438,790
+613,500
+8% +$45M
2013 Q2
3 quarters
THC icon
5
Tenet Healthcare
THC
$21.9B
$591M 3.87%
13,812,831
– –
2013 Q2
3 quarters
HUM icon
6
Humana
HUM
$51.3B
$579M 3.79%
5,132,182
+1,791,683
+54% +$187M
2013 Q2
3 quarters
FLEX icon
7
Flex
FLEX
$37.7B
$556M 3.64%
79,860,133
– –
2013 Q2
3 quarters
AIG icon
8
American International
AIG
$40.2B
$493M 3.23%
9,853,198
+1,233,134
+14% +$61.3M
2013 Q2
3 quarters
CYH icon
9
Community Health Systems
CYH
$420M
$474M 3.1%
14,633,492
+3,171,561
+28% +$105M
2013 Q2
3 quarters
PVH icon
10
PVH
PVH
$3.76B
$442M 2.9%
3,543,208
+955,007
+37% +$118M
2013 Q2
3 quarters
MCK icon
11
McKesson
MCK
$113B
$425M 2.79%
2,408,550
-642,375
-21% -$112M
2013 Q2
3 quarters
ELV icon
12
Elevance Health
ELV
$91.6B
$421M 2.76%
+4,231,950
New +$383M
2014 Q1
0 quarters
AET
13
DELISTED
Aetna Inc
AET
$402M 2.64%
5,366,213
+3,550,772
+196% +$251M
2013 Q4
1 quarter
TWC
14
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$383M 2.51%
2,795,260
-227,822
-8% -$31.2M
2013 Q2
3 quarters
DG icon
15
Dollar General
DG
$28B
$362M 2.37%
6,524,112
+3,576,700
+121% +$208M
2013 Q3
2 quarters
HRI icon
16
Herc Holdings
HRI
$4.07B
$353M 2.31%
+4,421,164
New +$356M
2014 Q1
0 quarters
WBA icon
17
DELISTED
Walgreens Boots Alliance
WBA
$343M 2.25%
5,190,926
-760,600
-13% -$47.8M
2013 Q2
3 quarters
CSC
18
DELISTED
Computer Sciences
CSC
$320M 2.09%
12,468,079
-229,106
-2% -$5.76M
2013 Q2
3 quarters
EBAY icon
19
eBay
EBAY
$52.2B
$298M 1.95%
+12,815,852
New +$298M
2014 Q1
0 quarters
TMUS icon
20
T-Mobile US
TMUS
$166B
$279M 1.83%
8,448,538
+3,488,232
+70% +$111M
2013 Q2
3 quarters
FOSL icon
21
Fossil Group
FOSL
$406M
$271M 1.77%
2,323,688
+1,493,512
+180% +$174M
2013 Q2
3 quarters
C icon
22
Citigroup
C
$207B
$247M 1.62%
5,181,395
+2,037,400
+65% +$101M
2013 Q2
3 quarters
LPNT
23
DELISTED
LifePoint Health, Inc.
LPNT
$234M 1.53%
4,280,637
-300,000
-7% -$16M
2013 Q2
3 quarters
AMAT icon
24
Applied Materials
AMAT
$357B
$225M 1.48%
+11,039,080
New +$203M
2014 Q1
0 quarters
PARA icon
25
DELISTED
Paramount Global Class B
PARA
$192M 1.25%
3,098,758
-1,350,744
-30% -$85.2M
2013 Q2
3 quarters
1
2 3 4

Similar funds

GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Glenview Capital Management's Q1 2014 Portfolio in Review

As of Q1 2014, Glenview Capital Management held 87 positions worth $15.3B, up 9.3% from $14B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Glenview Capital Management deployed $1.54B of net new capital in Q1 2014, opening 20 new positions and adding to 18 existing holdings. Its largest new stake was Elevance Health: 4,231,950 shares worth $421M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Pentair, an estimated $191M trimmed.

  • Glenview Capital Management's largest Q1 2014 buy was Elevance Health: 4,231,950 shares worth $421M.
  • Glenview Capital Management added most to Monsanto Co in Q1 2014, an estimated $266M increase.
  • Glenview Capital Management's biggest Q1 2014 reduction was Pentair, cutting an estimated $191M.
  • Glenview Capital Management fully exited HEALTH MGMT ASSOC INC CL-A in Q1 2014, selling an estimated $495M.
  • Glenview Capital Management's ten largest holdings make up 42% of its $15.3B portfolio in Q1 2014.
  • Glenview Capital Management opened 20 new positions and closed 19 in Q1 2014.
  • Glenview Capital Management's portfolio value rose 9.3% quarter-over-quarter to $15.3B.

Based on Glenview Capital Management's 13F filing for Q1 2014, filed 15 May 2014.